178 related articles for article (PubMed ID: 23707811)
1. Peptide p5 binds both heparinase-sensitive glycosaminoglycans and fibrils in patient-derived AL amyloid extracts.
Martin EB; Williams A; Heidel E; Macy S; Kennel SJ; Wall JS
Biochem Biophys Res Commun; 2013 Jun; 436(1):85-9. PubMed ID: 23707811
[TBL] [Abstract][Full Text] [Related]
2. Preclinical Validation of the Heparin-Reactive Peptide p5+14 as a Molecular Imaging Agent for Visceral Amyloidosis.
Wall JS; Martin EB; Richey T; Stuckey AC; Macy S; Wooliver C; Williams A; Foster JS; McWilliams-Koeppen P; Uberbacher E; Cheng X; Kennel SJ
Molecules; 2015 Apr; 20(5):7657-82. PubMed ID: 25923515
[TBL] [Abstract][Full Text] [Related]
3. Specific Amyloid Binding of Polybasic Peptides In Vivo Is Retained by β-Sheet Conformers but Lost in the Disrupted Coil and All D-Amino Acid Variants.
Wall JS; Williams A; Richey T; Stuckey A; Wooliver C; Christopher Scott J; Donnell R; Martin EB; Kennel SJ
Mol Imaging Biol; 2017 Oct; 19(5):714-722. PubMed ID: 28229334
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of a prototypic pan-amyloid clearing agent - a novel murine peptide-immunoglobulin fusion.
Foster JS; Balachandran M; Hancock TJ; Martin EB; Macy S; Wooliver C; Richey T; Stuckey A; Williams AD; Jackson JW; Kennel SJ; Wall JS
Front Immunol; 2023; 14():1275372. PubMed ID: 37854603
[TBL] [Abstract][Full Text] [Related]
5. Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
Castillo GM; Cummings JA; Yang W; Judge ME; Sheardown MJ; Rimvall K; Hansen JB; Snow AD
Diabetes; 1998 Apr; 47(4):612-20. PubMed ID: 9568695
[TBL] [Abstract][Full Text] [Related]
6. The pattern recognition reagents RAGE VC1 and peptide p5 share common binding sites and exhibit specific reactivity with AA amyloid in mice.
Kennel SJ; Williams A; Stuckey A; Richey T; Wooliver C; Chazin W; Stern DA; Martin EB; Wall JS
Amyloid; 2016; 23(1):8-16. PubMed ID: 26701064
[TBL] [Abstract][Full Text] [Related]
7. Role of glycosaminoglycan sulfation in the formation of immunoglobulin light chain amyloid oligomers and fibrils.
Ren R; Hong Z; Gong H; Laporte K; Skinner M; Seldin DC; Costello CE; Connors LH; Trinkaus-Randall V
J Biol Chem; 2010 Nov; 285(48):37672-82. PubMed ID: 20870723
[TBL] [Abstract][Full Text] [Related]
8. In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides.
Wall JS; Richey T; Stuckey A; Donnell R; Macy S; Martin EB; Williams A; Higuchi K; Kennel SJ
Proc Natl Acad Sci U S A; 2011 Aug; 108(34):E586-94. PubMed ID: 21807994
[TBL] [Abstract][Full Text] [Related]
9. Heparin binds 8 kDa gelsolin cross-β-sheet oligomers and accelerates amyloidogenesis by hastening fibril extension.
Solomon JP; Bourgault S; Powers ET; Kelly JW
Biochemistry; 2011 Apr; 50(13):2486-98. PubMed ID: 21348501
[TBL] [Abstract][Full Text] [Related]
10. Discrete binding patterns of two heparin-reactive proteins, basic fibroblast growth factor and peptide p5R, in amyloid-laden and healthy mice.
Martin EB; Donnell R; Richey T; Stuckey A; Kennel SJ; Wall JS
Biochem Biophys Res Commun; 2021 May; 552():136-141. PubMed ID: 33744761
[TBL] [Abstract][Full Text] [Related]
11. Bifunctional amyloid-reactive peptide promotes binding of antibody 11-1F4 to diverse amyloid types and enhances therapeutic efficacy.
Wall JS; Williams AD; Foster JS; Richey T; Stuckey A; Macy S; Wooliver C; Campagna SR; Tague ED; Farmer AT; Lands RH; Martin EB; Heidel RE; Kennel SJ
Proc Natl Acad Sci U S A; 2018 Nov; 115(46):E10839-E10848. PubMed ID: 30377267
[TBL] [Abstract][Full Text] [Related]
12. Macromolecular properties of glycosaminoglycans in primary AL amyloid fibril extracts of lymphoid tissue origin.
Stenstad T; Magnus JH; Kolset SO; Cornwell GG; Husby G
Scand J Immunol; 1991 Nov; 34(5):611-7. PubMed ID: 1947796
[TBL] [Abstract][Full Text] [Related]
13. The sulfate moieties of glycosaminoglycans are critical for the enhancement of beta-amyloid protein fibril formation.
Castillo GM; Lukito W; Wight TN; Snow AD
J Neurochem; 1999 Apr; 72(4):1681-7. PubMed ID: 10098877
[TBL] [Abstract][Full Text] [Related]
14. Differential effects on light chain amyloid formation depend on mutations and type of glycosaminoglycans.
Blancas-Mejía LM; Hammernik J; Marin-Argany M; Ramirez-Alvarado M
J Biol Chem; 2015 Feb; 290(8):4953-4965. PubMed ID: 25538238
[TBL] [Abstract][Full Text] [Related]
15. Heparin promotes the rapid fibrillization of a peptide with low intrinsic amyloidogenicity.
Madine J; Davies HA; Hughes E; Middleton DA
Biochemistry; 2013 Dec; 52(50):8984-92. PubMed ID: 24279288
[TBL] [Abstract][Full Text] [Related]
16. High molecular weight glycosaminoglycans in AA type amyloid fibril extracts from human liver.
Magnus JH; Kolset SO; Husby G
Ann Rheum Dis; 1991 Aug; 50(8):562-6. PubMed ID: 1888198
[TBL] [Abstract][Full Text] [Related]
17. Preclinical evaluation of Tc-99m p5+14 peptide for SPECT detection of cardiac amyloidosis.
Kennel SJ; Jackson JW; Stuckey A; Richey T; Foster JS; Wall JS
PLoS One; 2024; 19(4):e0301756. PubMed ID: 38578730
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of p5+14 with SAP and peptide p5 by dual-energy SPECT imaging of mice with AA amyloidosis.
Martin EB; Williams A; Richey T; Stuckey A; Heidel RE; Kennel SJ; Wall JS
Sci Rep; 2016 Mar; 6():22695. PubMed ID: 26936002
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
